Anticuerpos antilipoproteinas de baja densidad e inmunocomplejos APO (B) lipoproteina-anticuerpo en pacientes con enfermedad vascular perifèrica: empleo de anticuerpos monoclonales

Sorell Gòmez, Luis; Lòpez Ruiz, Justo; Fernàndez Montequin, Josè; Romero Valdès, Alexis; Oliù Torres, Omar.
Rev. cuba. invest. bioméd ; 8(3): 219-30, sept.-dic. 1989. ilus
Artículo en Español | LILACS | ID: lil-85398

Documentos relacionados

  1. Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence.
  2. Biochemical and functional characterization of charge-defined subfractions of high-density lipoprotein from normal adults.
  3. A Single In-Vial Dual Extraction Strategy for the Simultaneous Lipidomics and Proteomics Analysis of HDL and LDL Fractions.
  4. Intracellular APOL1 Risk Variants Cause Cytotoxicity Accompanied by Energy Depletion.
  5. Resolution of Lipoprotein Subclasses by Charge Detection Mass Spectrometry.
  6. The HDL lipidome is widely remodeled by fast food versus Mediterranean diet in 4 days.
  7. Allergic rhinitis is associated with complex alterations in high-density lipoprotein composition and function.
  8. The Changing Face of HDL and the Best Way to Measure It.
  9. Automation of PRM-dependent D3-Leu tracer enrichment in HDL to study the metabolism of apoA-I, LCAT and other apolipoproteins.
  10. Simple method for analysis of apolipoproteins in high density lipoproteins by high performance liquid chromatography.